Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Claudio Argento
AddedFeb 15, 2024
UpdatedMay 31, 2026
Claudio Argento

Claudio Argento

Founder, Myra Vision

CrunchbaseLinkedInThe Org

Claudio Argento's Career

Myra Vision
Myra Vision

Campbell, CA, US

Founder
Atia Vision
Atia Vision

Campbell, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Claudio Argento's Career

Myra Vision
Myra Vision
$50.5M202016Campbell, CA, US
Founder

Leadership at Myra Vision

Robert ChangRobert ChangCEO

Similar to Myra Vision

GlaukosGlaukosSan Clemente, CA, USMedical Devicesest. 1998GlaukosSan Clemente, CA, US · est. 1998

Glaukos Corp: A public ophthalmic tech firm developing and marketing micro-scale therapies for glaucoma.

Public · $121M783
Forsight Vision6Forsight Vision6Menlo Park, CA, USMedical Devicesest. 2014Forsight Vision6Menlo Park, CA, US · est. 2014

ForSight VISION6: A healthcare company specializing in ophthalmic solutions for visual impairments.

$7M18
IrisVisionIrisVisionPleasanton, CA, USOptical Instrumentsest. 2013IrisVisionPleasanton, CA, US · est. 2013

IrisVision Global: A US-based vision tech company designing and manufacturing innovative optical instruments.

Public · $21.7M81
MicroOptxMicroOptxMaple Grove, MN, USMedical Devicesest. 2014MicroOptxMaple Grove, MN, US · est. 2014

MicroOptx: A medical device company innovating platform technology for eye health solutions.

$19.2M15
Atia Vision
Atia Vision
$111.1M292012Campbell, CA, US
Founder

Leadership at Atia Vision

Mariam MaghribiMariam MaghribiCEO
Casey GordonCasey GordonBoard Member

Similar to Atia Vision

RxSightRxSightAliso Viejo, CA, USMedical Devicesest. 1997RxSightAliso Viejo, CA, US · est. 1997

RxSight®, based in California, is the pioneer in adjustable intraocular lenses, revolutionizing cataract surgery.

Public · $236M292
Sight SciencesSight SciencesMenlo Park, CA, USMedical Devicesest. 2011Sight SciencesMenlo Park, CA, US · est. 2011

Sight Sciences, Inc.: A California-based medical device company specializing in vision health.

Public · $173.7M250
AtaiaAtaiaRoswell, GA, USCommunication Aidsest. 2017AtaiaRoswell, GA, US · est. 2017

Ataia Medical: Empowering patients with innovative communication solutions.

$300k7
ClearsightClearsightAurora, CO, USIntraocular Lensesest. 2012ClearsightAurora, CO, US · est. 2012

ClearSight develops premium intraocular lenses for post-cataract surgery vision enhancement.

$1M5

People Similar to Claudio Argento

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao